SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The SolyCat is a symbol of energy and mystery. Shining like the sun and agile as a feline.  Solycat is here to take over Solana! Inspired by Shiba Inu’s legendary rise on Ethereum, Solycat is the ultimate meme coin designed for Solana’s fast and scalable blockchain.  Our mission is simple: become the top cat of Solana. With bold branding, a vibrant community, and unstoppable momentum, Solycat is ready to dominate. This isn’t just another token—it’s a movement powered by fun, creativity, and the spirit of decentralization.  Join the pride and let’s make history, one paw at a time!

Solycat

Solycat ($SOLYCAT) is gaining traction, with community members highlighting its availability on Phantom Wallet and relative stability amidst market fluctuations. The crypto is being touted as a potential "moon" candidate, with buyers sharing enthusiasm. Conversations are centered on its performance within the Solana ecosystem.

Moo Deng

MOODENG is trending as traders discuss recent price volatility and potential for a breakout. Community members are debating entry points, with some pointing to technical analysis patterns, while others express skepticism, citing its meme coin status and past performance. The coin's listing on Robinhood and upcoming birthday are also being mentioned as potential catalysts.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

GBTC is trending as Bitcoin flirts with all-time highs, driving discussion about potential breakouts and future price targets. Community members are closely watching technical indicators and whale activity, anticipating a continued uptrend. Broader market factors, like potential shifts from gold to Bitcoin and the impact of government policies, are also being considered.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMA Biologics is trending amid discussions about a potential recall of specific lots and the impact on revenue, with community members analyzing the company's response and comparing it to similar situations with competitors. Some traders are interpreting recent stock sales by the CEO, alongside an FDA safety notice, while others suggest potential manufacturing issues. Despite concerns, many community members express confidence in the company's long-term growth and potential for a buyback.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.

Tonix Pharmaceuticals Holding Corp

TNXP is trending as the stock price continues to drop post FDA approval, leading to discussions around management, dilution, and future prospects. The community is debating whether the current price represents a buying opportunity or reflects deeper issues with the company's leadership and commercialization strategy. Some traders are noting potential short squeeze setups due to high short interest.

ProShares Trust - ProShares Short Dow30 -1x Shares

ProShares Short Dow30

$DOG, a ProShares Short Dow30 ETF, is trending as traders discuss its potential for hedging against a possible market pullback, particularly with the Dow showing signs of volatility. The community highlights call options and celebrates the strong community supporting the Bitcoin-native meme coin, $DOG, with some anticipating major exchange listings and comparing it to early Dogecoin.

Tidal Trust II - YieldMax Ultra Option Income Strategy ETF

YieldMax Ultra Option Income Strategy ETF

ULTY is trending as investors discuss dividend payouts, NAV erosion, and overall profitability; some express concern over the fund's long-term viability. Community members are weighing strategies like reinvesting dividends versus taking profits, with some considering alternative high-yield ETFs.  Broader discussions include the impact of market volatility and potential reverse splits.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

KENDU is trending due to growing community engagement and real-world applications, with discussions focusing on its expanding ecosystem and the potential for significant growth. Community members highlight KENDU's unique approach as a permissionless brand, its active IRL presence, and the increasing number of holders. The recent release of a new website is also generating excitement, with many expressing confidence in KENDU's long-term potential.

Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company, which includes a pipeline of novel biologic therapeutic candidates, developed using proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize multivalent formats where the precise valency can be optimized in a target-centric way to mediate what is believed to be the most appropriate agonist function. The company was founded by Brendan P. Eckelman on January 8, 2024 and is headquartered in La Jolla, CA.

Inhibrx Biosciences Inc.

Inhibrx Inc

Inhibrx ($INBX) is trending due to positive updates on its INBRX-101 drug for AATD, specifically regarding a functional alpha-1 antitrypsin serum levels endpoint, leading to speculation about accelerated FDA approval; the community is actively discussing its potential and analyst target price increase. Some traders are noting its low float and potential for a short squeeze, while others are wary of a possible upcoming offering.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending as the community anticipates the Kraken listing and speculates on potential Coinbase and Binance listings. Discussions revolve around the project's potential for mainstream adoption, partnerships with NBA and NHL, and the upcoming Super App. Some users are debating the project's legitimacy and comparing it to XRP.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Transformation Gobbles Up Smart Share Global's profits

Key Takeaways:
Smart Share Global's revenue plunged more than 50% in the first quarter, as revenue from its core charging services tumbled amid its business transformation
The company is gradually...

Q4 2023 Smart Share Global Ltd Earnings Call Transcript

Smart Share Global Limited (EM) Q4 2023 Earnings Call Transcript

Smart Share Global Limited (EM) Q4 2023 Earnings Call Transcript...

Smart Share Global Limited (EM) Q1 2024 Earnings Call Transcript

Smart Share Global Limited (EM) Q1 2024 Earnings Call Transcript...

Smart Share Global Limited Announces Fourth Quarter and Fiscal Year 2023 Results

Net income was RMB87.7 million for full year 2023Mobile device charging orders1 increased 32.8% year-over-year during the fourth quarter of 2023 SHANGHAI, China, March 28, 2024 (GLOBE NEWSWIRE...

Smart Share Global Limited to Report Fourth Quarter and Fiscal Year 2023 Results on March 28, 2024

SHANGHAI, China, March 20, 2024 (GLOBE NEWSWIRE) -- Smart Share Global Limited (Nasdaq: EM) ( Energy Monster or the Company ), a consumer tech company providing mobile device charging service...

Even With A 38% Surge, Cautious Investors Are Not Rewarding Smart Share Global Limited's (NASDAQ:EM) Performance Completely

Smart Share Global Limited ( NASDAQ:EM ) shares have had a really impressive month, gaining 38% after a shaky period...

12 acciones de consumo discrecional en movimiento en la sesi n intrad a del 11/03/2024

Acciones al alza
Ballys (NYSE:BALY) subieron un 26,17% para establecerse en los 13,40 d lares durante la sesi n del regular del lunes.
Smart Share Glb (NASDAQ:EM) subieron un 13,93% para establecerse...

Smart Share Global Limited Declares a Special Cash Dividend

SHANGHAI, China, March 11, 2024 (GLOBE NEWSWIRE) -- Smart Share Global Limited (Nasdaq: EM) ( Energy Monster or the Company ), a consumer tech company providing mobile device charging service...

Smart Share Global Ltd. operates as a consumer tech company providing mobile device charging service through an online and offline network. It provides service through its power banks, placed in POIs operated by location partners, such as entertainment venues, restaurants, shopping centers, hotels, transportation hubs and public spaces. The company was founded by Guang Yuan Cai, Pei Feng Xu, Yaoyu Zhang and Xiaowei Li in May 2017 and is headquartered in Shanghai, China.

Smart Share Global Ltd - ADR

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '24	$0.00	$0.00	-100.00%	MISSED
Q4 '23	--	$0.00	--	N/A
Q3 '23	$0.04	$0.01	-68.39%	MISSED
Q2 '23	$0.05	$0.01	-84.55%	MISSED
Q1 '23	-$0.02	$0.00	115.65%	BEAT

EM
Smart Share Global Ltd.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '24

Historical Earnings

Latest EM News

EMSmart Share Global Ltd.